9 Liraglutide (Saxenda): a daily injection often used by those who prefer a shorter-acting medication or are just beginning therapy
This could be related to the body adjusting to the medication, changes in blood sugar levels, or individual sensitivities
For anyone on those additional medications, the article calls for close glucose monitoring and a medication review with the prescriber before making the dietary change, not after symptoms appear
Like the Wegovy pen, the pill contains semaglutide and is FDA-approved for chronic weight management
Weight loss effects of GLP-1RAs Liraglutide (3.0 mg, Saxenda), a GLP-1RA that activates the GLP-1 receptor, was approved by the FDA in December 2014 for adult obesity treatment [38] and has recently shown efficacy in adolescents aged 12 to 18 years
GLP-1 is a coronary artery vasodilator in humans